PubMedID: 17526459Investigators in this study explored levels of soluble CD27 (sCD27), interleukin (IL)-8, and IL-10 in B-cell chronic lymphocytic leukemia (B-CLL), and the correlation of these levels with disease stage and prognosis. Plasma IL-8, IL-10, and sCD27 levels were assessed with enzyme-linked immunosorbent assay tests in 22 healthy donors and 70 patients with B-CLL (49 men and 21 women). Mean patient age was 61.57 y (range, 44-75 y). Mean healthy donor age was 62.09 y (range, 40-72 y). In the study group, mean values were as follows: plasma IL-8, 284.758 pg/mL (0-1000 pg/mL); plasma IL-10, 26.152 pg/mL (0-100 pg/mL); sCD27, 731.357 U/mL (139.9-1000 U/mL); white blood cell count, 59.9 × 10 9/L (0.8-250.0 × 10 9/L); hemoglobin coun...
Chronic lymphocytic leukemia (CLL) is a lymphoid neoplasm characterized by the accumulation of matur...
Chronic lymphocyte leukemia (CLL) is a B-cell malignancy resisted to apoptosis. Recently, some studi...
Objective: Chronic lymphocytic leukemia (CLL) is a disease that shows varying clinical progression, ...
WOS: 000246229900004PubMed ID: 17526459Investigators in this study explored levels of soluble CD27 (...
Soluble CD23 (sCD23) levels correlate with the stage, prognosis and overall survival (OS) of patient...
Background and objectives: to investigate whether CD38 expression at diagnosis is an independent pre...
A number of serum parameters such as thymidine kinase (TK), beta2microglobulin (B2-MG) and soluble C...
We measured the soluble (s) receptors CD23, CD8, CD4, interleukin-2 receptor (IL-2R, CD25), and tran...
Chronic lymphocytic leukemia (CLL) is a lymphoid neoplasm characterized by the accumulation of matur...
Chronic lymphocytic leukemia (CLL) is a lymphoid neoplasm characterized by the accumulation of matur...
The purpose of this study was to assess in chronic lymphocytic leukaemia (CLL) patients the prevalen...
Background: Several immunological parameters have been investigated in patients with chronic lymphoc...
The course of chronic lymphocytic leukemia(CLL) is variable. In aggressive disease, the CLL usually...
Chronic lymphocytic leukemia (CLL) is a lymphoid neoplasm characterized by the accumulation of matur...
Background: B-chronic lymphocytic leukemia (CLL) is a monoclonal malignancy characterized by an accu...
Chronic lymphocytic leukemia (CLL) is a lymphoid neoplasm characterized by the accumulation of matur...
Chronic lymphocyte leukemia (CLL) is a B-cell malignancy resisted to apoptosis. Recently, some studi...
Objective: Chronic lymphocytic leukemia (CLL) is a disease that shows varying clinical progression, ...
WOS: 000246229900004PubMed ID: 17526459Investigators in this study explored levels of soluble CD27 (...
Soluble CD23 (sCD23) levels correlate with the stage, prognosis and overall survival (OS) of patient...
Background and objectives: to investigate whether CD38 expression at diagnosis is an independent pre...
A number of serum parameters such as thymidine kinase (TK), beta2microglobulin (B2-MG) and soluble C...
We measured the soluble (s) receptors CD23, CD8, CD4, interleukin-2 receptor (IL-2R, CD25), and tran...
Chronic lymphocytic leukemia (CLL) is a lymphoid neoplasm characterized by the accumulation of matur...
Chronic lymphocytic leukemia (CLL) is a lymphoid neoplasm characterized by the accumulation of matur...
The purpose of this study was to assess in chronic lymphocytic leukaemia (CLL) patients the prevalen...
Background: Several immunological parameters have been investigated in patients with chronic lymphoc...
The course of chronic lymphocytic leukemia(CLL) is variable. In aggressive disease, the CLL usually...
Chronic lymphocytic leukemia (CLL) is a lymphoid neoplasm characterized by the accumulation of matur...
Background: B-chronic lymphocytic leukemia (CLL) is a monoclonal malignancy characterized by an accu...
Chronic lymphocytic leukemia (CLL) is a lymphoid neoplasm characterized by the accumulation of matur...
Chronic lymphocyte leukemia (CLL) is a B-cell malignancy resisted to apoptosis. Recently, some studi...
Objective: Chronic lymphocytic leukemia (CLL) is a disease that shows varying clinical progression, ...